BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2719908)

  • 1. Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II).
    Marrot L; Leng M
    Biochemistry; 1989 Feb; 28(4):1454-61. PubMed ID: 2719908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence.
    Anin MF; Leng M
    Nucleic Acids Res; 1990 Aug; 18(15):4395-400. PubMed ID: 2388824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortions induced in DNA by cis-platinum interstrand adducts.
    Sip M; Schwartz A; Vovelle F; Ptak M; Leng M
    Biochemistry; 1992 Mar; 31(9):2508-13. PubMed ID: 1547234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).
    Schwartz A; Marrot L; Leng M
    Biochemistry; 1989 Oct; 28(20):7975-9. PubMed ID: 2605168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).
    Bellon SF; Coleman JH; Lippard SJ
    Biochemistry; 1991 Aug; 30(32):8026-35. PubMed ID: 1868076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong sequence-dependent polymorphism in adduct-induced DNA structure: analysis of single N-2-acetylaminofluorene residues bound within the NarI mutation hot spot.
    Belguise-Valladier P; Fuchs RP
    Biochemistry; 1991 Oct; 30(42):10091-100. PubMed ID: 1931941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA.
    Schwartz A; Leng M
    J Mol Biol; 1994 Mar; 236(4):969-74. PubMed ID: 8120904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).
    Corda Y; Job C; Anin MF; Leng M; Job D
    Biochemistry; 1991 Jan; 30(1):222-30. PubMed ID: 1988023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II).
    Brabec V; Síp M; Leng M
    Biochemistry; 1993 Nov; 32(43):11676-81. PubMed ID: 8218235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove.
    Rice JA; Crothers DM; Pinto AL; Lippard SJ
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4158-61. PubMed ID: 3380785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
    Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
    Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA bending by acetylaminofluorene residues and by apurinic sites.
    Schwartz A; Marrot L; Leng M
    J Mol Biol; 1989 May; 207(2):445-50. PubMed ID: 2754732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acids.
    Malinge JM; Schwartz A; Leng M
    Nucleic Acids Res; 1987 Feb; 15(4):1779-97. PubMed ID: 3822839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y; Anin MF; Leng M; Job D
    Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA double helix promotes a linkage isomerization reaction in trans-diamminedichloroplatinum(II)-modified DNA.
    Dalbiès R; Payet D; Leng M
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8147-51. PubMed ID: 8058771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
    Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA.
    Malinge JM; Pérez C; Leng M
    Nucleic Acids Res; 1994 Sep; 22(19):3834-9. PubMed ID: 7937101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.
    Poklar N; Pilch DS; Lippard SJ; Redding EA; Dunham SU; Breslauer KJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7606-11. PubMed ID: 8755522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro.
    Vrána O; Brabec V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Dec; 50(6):995-1007. PubMed ID: 3491805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
    Chválová K; Sari MA; Bombard S; Kozelka J
    J Inorg Biochem; 2008 Feb; 102(2):242-50. PubMed ID: 17961652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.